Inhibitory effect of rhubarb on intestinal α-glucosidase activity in type 1 diabetic rats
Purpose: To investigate the inhibitory effect of rhubarb on α-glucosidase activity in the small intestine of rats with type 1 diabetes.
Methods: Type 1 diabetic rat model was established by intraperitoneally injecting 30 male SD rats with 1 % streptozocin (STZ). Rats with fasting blood glucose > 11 mmol/L (24) were used for the study. The rats were randomly divided into three equal groups including control, acarbose and rhubarb groups. Arcabose® (20 mg/kg /day) and rhubarb (100 mg/kg /day) were given by intra-gastric route via insertion of the cannula through the esophagus. Daily fasting blood glucose and daily postprandial glucose levels were assayed for all groups. On day 6, postprandial blood glucose, blood levels of C-peptide and insulin, and intestinal α-glucosidase were also determined.
Results: There were no significant differences in levels of C-peptide, insulin and fasting blood glucose between control, Acarbose® and rhubarb groups (p > 0.05). However, α-glucosidase activity at 0, 30, 60 and 120 min in the rhubarb group was 1759.2, 1812.8, 1379.8 and 772.1 U, respectively,) while in the Acarbose® group it was 178.6, 1260.1, 1126.5, 599.2 U, respectively. α-Glucosidase activity in both groups initially showed an increase (p < 0.05), followed by a decline from 60 to 120 min (p ˂ 0.05). After 120 min, α-glucosidase activity in each of the two groups was significantly decreased compared with untreated control (1200 U) (p ˂ 0.05).
Conclusion: The inhibitory effect of rhubarb on intestinal α-glucosidase activity of Type 1 diabetic rats is comparable to that of Arcabose®.This suggests that this plant may have clinically potent anti-diabetic properties.
Keywords: Type 1 diabetes, α-Glucosidase activity, Acarbose®, Rhubarb, Postprandial glucose level
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.